Mechanism of action revealed for remdesivir, potential coronavirus drug

Share via

Researchers have demonstrated how the drug known as remdesivir works, presenting the viral RNA polymerase of coronaviruses as a target for these conditions.

Coronavirus cells

A team of academic and industry researchers has reported new findings on how exactly an investigational antiviral drug stops coronaviruses. The paper was published the same day that the US National Institutes of Health (NIH) announced that the drug in question, remdesivir, is being used in the country’s first clinical trial of an experimental treatment for COVID-19, the illness caused by the SARS-CoV-2 virus.

Previous research in cell cultures and animal models has shown that remdesivir can block replication of a variety of coronaviruses, but until now it has not been clear how it does so. The researchers, from the University of Alberta, US, and Gilead, studied the drug’s effects on the coronavirus that causes Middle East Respiratory Syndrome (MERS). They found that remdesivir blocks a particular enzyme that is required for viral replication. 

Coronaviruses replicate by copying their genetic material using an enzyme known as the RNA-dependent RNA polymerase. Until now, it has been difficult to get the polymerase complex that contains multiple proteins to work in a test tube.

“It hasn’t been easy to work with these viral polymerases,” Matthias Götte, a virologist and professor at the University of Alberta who led the study. He explained that this has slowed research into new drugs’ function. 

Using polymerase enzymes from the coronavirus that causes MERS, scientists in Götte’s lab found that the enzymes can incorporate remdesivir, which resembles an RNA building block, into new RNA strands. Shortly after adding remdesivir, the enzyme stops being able to add more RNA subunits. This halts genome replication.

The scientists hypothesise that this might happen because RNA containing remdesivir takes on a strange shape that does not fit into the enzyme. To find out for certain, they would need to collect structural data on the enzyme and newly synthesised RNA. Such data could also help researchers design future drugs to have even greater activity against the polymerase. They suggest the viral RNA polymerase of coronaviruses as a target.

The study was published in the Journal of Biological Chemistry.

5 responses to “Mechanism of action revealed for remdesivir, potential coronavirus drug”

  1. Why do some patients show no symptoms at all??? WHY? Is it because their body possess an abundance of certain enzymes that inhibit virus replication? What is that enzyme?

    • Razia Jafri says:

      asymptomatic infection can be seen by 2 mechanisms
      1. due to variability in receptor gene expression which may vary between individuals as well as between cells, for COVID 19 receptor is ACE2 see below
      ACE2provided by HGNC
      Official Full Name
      angiotensin I converting enzyme 2provided by HGNC
      Primary source
      See related
      Ensembl:ENSG00000130234 MIM:300335
      Gene type
      protein coding
      RefSeq status
      Homo sapiens
      Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo
      Also known as
      The protein encoded by this gene belongs to the angiotensin-converting enzyme family of dipeptidyl carboxydipeptidases and has considerable homology to human angiotensin 1 converting enzyme. This secreted protein catalyzes the cleavage of angiotensin I into angiotensin 1-9, and angiotensin II into the vasodilator angiotensin 1-7. The organ- and cell-specific expression of this gene suggests that it may play a role in the regulation of cardiovascular and renal function, as well as fertility. In addition, the encoded protein is a functional receptor for the spike glycoprotein of the human coronavirus HCoV-NL63 and the human severe acute respiratory syndrome coronaviruses, SARS-CoV and SARS-CoV-2 (COVID-19 virus). [provided by RefSeq, Mar 2020]
      Biased expression in small intestine (RPKM 93.7), duodenum (RPKM 69.0) and 5 other tissues See more

      The other reason for severity is underlying diseases, people with chronic lung disease do not have much functional cell reserves and when cells are infected their function declines rapidly

  2. Ron Wetherall Pharm says:

    Based on the comments of Razia Jafri, what effect would occur to patients on ACE inhibitors ?

  3. Ron Wetherall says:

    What effect would occur on patients on ACE inhibitors who are exposed to Corona virus 19?

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Send this to a friend